TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
03 2022
Historique:
received: 02 04 2021
accepted: 18 01 2022
pubmed: 25 2 2022
medline: 23 4 2022
entrez: 24 2 2022
Statut: ppublish

Résumé

Variants of UNC13A, a critical gene for synapse function, increase the risk of amyotrophic lateral sclerosis and frontotemporal dementia

Identifiants

pubmed: 35197628
doi: 10.1038/s41586-022-04436-3
pii: 10.1038/s41586-022-04436-3
pmc: PMC8891020
doi:

Substances chimiques

Codon, Nonsense 0
DNA-Binding Proteins 0
Nerve Tissue Proteins 0
TARDBP protein, human 0
UNC13B protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-137

Subventions

Organisme : Medical Research Council
ID : MR/M008606/1
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : T32 GM136577
Pays : United States
Organisme : Medical Research Council
ID : MR/R005184/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_MR/S022708/1
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : TURNER/OCT15/972-797
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S006508/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_MR/N501931/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107116/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W005190/1
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : FRATTA/JAN15/946-795
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R56 AG055824
Pays : United States
Organisme : Wellcome Trust
ID : FC001002
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : U01 AG068880
Pays : United States
Organisme : Motor Neurone Disease Association
ID : HALLEGGER/OCT15/959-799
Pays : United Kingdom
Organisme : Motor Neurone Disease Association
ID : MALASPINA/APR13/817-791
Pays : United Kingdom

Investigateurs

Hemali Phatnani (H)
Justin Kwan (J)
Dhruv Sareen (D)
James R Broach (JR)
Zachary Simmons (Z)
Ximena Arcila-Londono (X)
Edward B Lee (EB)
Vivianna M Van Deerlin (VM)
Neil A Shneider (NA)
Ernest Fraenkel (E)
Lyle W Ostrow (LW)
Frank Baas (F)
Noah Zaitlen (N)
James D Berry (JD)
Andrea Malaspina (A)
Pietro Fratta (P)
Gregory A Cox (GA)
Leslie M Thompson (LM)
Steve Finkbeiner (S)
Efthimios Dardiotis (E)
Timothy M Miller (TM)
Siddharthan Chandran (S)
Suvankar Pal (S)
Eran Hornstein (E)
Daniel J MacGowan (DJ)
Terry Heiman-Patterson (T)
Molly G Hammell (MG)
Nikolaos A Patsopoulos (NA)
Oleg Butovsky (O)
Joshua Dubnau (J)
Avindra Nath (A)
Robert Bowser (R)
Matthew Harms (M)
Eleonora Aronica (E)
Mary Poss (M)
Jennifer Phillips-Cremins (J)
John Crary (J)
Nazem Atassi (N)
Dale J Lange (DJ)
Darius J Adams (DJ)
Leonidas Stefanis (L)
Marc Gotkine (M)
Robert H Baloh (RH)
Suma Babu (S)
Towfique Raj (T)
Sabrina Paganoni (S)
Ophir Shalem (O)
Colin Smith (C)
Bin Zhang (B)
Brent Harris (B)
Iris Broce (I)
Vivian Drory (V)
John Ravits (J)
Corey McMillan (C)
Vilas Menon (V)
Lani Wu (L)
Steven Altschuler (S)
Yossef Lerner (Y)
Rita Sattler (R)
Kendall Van Keuren-Jensen (K)
Orit Rozenblatt-Rosen (O)
Kerstin Lindblad-Toh (K)
Katharine Nicholson (K)
Peter Gregersen (P)
Jeong-Ho Lee (JH)
Sulev Kokos (S)
Stephen Muljo (S)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022. The Author(s).

Références

van Es, M. A. et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat. Genet. 41, 1083–1087 (2009).
pubmed: 19734901 doi: 10.1038/ng.442
Pottier, C. et al. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathol. 137, 879–899 (2019).
pubmed: 30739198 pmcid: 6533145 doi: 10.1007/s00401-019-01962-9
Diekstra, F. P. et al. C9orf72 and UNC13A are shared risk loci for ALS and FTD: a genome-wide meta-analysis. Ann. Neurol. 76, 120–133 (2014).
pubmed: 24931836 pmcid: 4137231 doi: 10.1002/ana.24198
Tan, R. H., Ke, Y. D., Ittner, L. M. & Halliday, G. M. ALS/FTLD: experimental models and reality. Acta Neuropathol. 133, 177–196 (2017).
pubmed: 28058507 doi: 10.1007/s00401-016-1666-6
Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133 (2006).
pubmed: 17023659 doi: 10.1126/science.1134108
Ji, A.-L., Zhang, X., Chen, W.-W. & Huang, W.-J. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum. J. Med. Genet. 54, 145–154 (2017).
pubmed: 28087719 doi: 10.1136/jmedgenet-2016-104271
Ling, J. P., Pletnikova, O., Troncoso, J. C. & Wong, P. C. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science 349, 650–655 (2015).
pubmed: 26250685 pmcid: 4825810 doi: 10.1126/science.aab0983
Melamed, Z. et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 22, 180–190 (2019).
pubmed: 30643298 pmcid: 6348009 doi: 10.1038/s41593-018-0293-z
Klim, J. R. et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 22, 167–179 (2019).
pubmed: 30643292 pmcid: 7153761 doi: 10.1038/s41593-018-0300-4
Prudencio, M. et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. J. Clin. Invest. 130, 6080–6092 (2020).
pubmed: 32790644 pmcid: 7598060 doi: 10.1172/JCI139741
Fernandopulle, M. S. et al. Transcription factor–mediated differentiation of human iPSCs into neurons. Curr. Protoc. Cell Biol. 79, e51 (2018).
pubmed: 29924488 pmcid: 6993937 doi: 10.1002/cpcb.51
Tian, R. et al. CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived Neurons. Neuron 104, 239–255.e12 (2019).
pubmed: 31422865 pmcid: 6813890 doi: 10.1016/j.neuron.2019.07.014
Wang, C. et al. Scalable production of iPSC-derived human neurons to identify Tau-lowering compounds by high-content screening. Stem Cell Rep. 9, 1221–1233 (2017).
doi: 10.1016/j.stemcr.2017.08.019
Humphrey, J., Emmett, W., Fratta, P., Isaacs, A. M. & Plagnol, V. Quantitative analysis of cryptic splicing associated with TDP-43 depletion. BMC Med. Genomics 10, 38 (2017).
pubmed: 28549443 pmcid: 5446763 doi: 10.1186/s12920-017-0274-1
Nicolas, A. et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 97, 1268–1283.e6 (2018).
pubmed: 29566793 pmcid: 5867896 doi: 10.1016/j.neuron.2018.02.027
Martin, A. R. et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat. Genet. 51, 1560–1565 (2019).
pubmed: 31676867 doi: 10.1038/s41588-019-0528-2
Diekstra, F. P. et al. UNC13A is a modifier of survival in amyotrophic lateral sclerosis. Neurobiol. Aging 33, 630.e3-8 (2012).
pubmed: 22118904 doi: 10.1016/j.neurobiolaging.2011.10.029
Placek, K. et al. UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 73, 190–199 (2019).
pubmed: 30368160 doi: 10.1016/j.neurobiolaging.2018.09.031
Yang, B. et al. UNC13A variant rs12608932 is associated with increased risk of amyotrophic lateral sclerosis and reduced patient survival: a meta-analysis. Neurol. Sci. 40, 2293–2302 (2019).
pubmed: 31201598 doi: 10.1007/s10072-019-03951-y
Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434–443 (2020).
pubmed: 32461654 pmcid: 7334197 doi: 10.1038/s41586-020-2308-7
Appocher, C. et al. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. Nucleic Acids Res. 45, 8026–8045 (2017).
pubmed: 28575377 pmcid: 5570092 doi: 10.1093/nar/gkx477
Tollervey, J. R. et al. Characterising the RNA targets and position-dependent splicing regulation by TDP-43; implications for neurodegenerative diseases. Nat. Neurosci. 14, 452–458 (2011).
pubmed: 21358640 pmcid: 3108889 doi: 10.1038/nn.2778
Liu, E. Y. et al. Loss of nuclear TDP-43 is associated with decondensation of LINE retrotransposons. Cell Rep. 27, 1409–1421.e6 (2019).
pubmed: 31042469 pmcid: 6508629 doi: 10.1016/j.celrep.2019.04.003
Zetoune, A. B. et al. Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues. BMC Genet. 9, 83 (2008).
pubmed: 19061508 pmcid: 2607305 doi: 10.1186/1471-2156-9-83
Couratier, P., Corcia, P., Lautrette, G., Nicol, M. & Marin, B. ALS and frontotemporal dementia belong to a common disease spectrum. Rev. Neurol. 173, 273–279 (2017).
pubmed: 28449882 doi: 10.1016/j.neurol.2017.04.001
Ma, X. R. et al. TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A. Nature https://doi.org/10.1038/s41586-022-04424-7 (2022).
Ray, D. et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature 499, 172–177 (2013).
pubmed: 23846655 pmcid: 3929597 doi: 10.1038/nature12311
Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923 (1993).
pubmed: 8346443 doi: 10.1126/science.8346443
Dittman, J. S. Unc13: a multifunctional synaptic marvel. Curr. Opin. Neurobiol. 57, 17–25 (2019).
pubmed: 30690332 pmcid: 6629506 doi: 10.1016/j.conb.2018.12.011
Augustin, I., Rosenmund, C., Südhof, T. C. & Brose, N. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature 400, 457–461 (1999).
pubmed: 10440375 doi: 10.1038/22768
Varoqueaux, F. et al. Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming. Proc. Natl Acad. Sci. USA 99, 9037–9042 (2002).
pubmed: 12070347 pmcid: 124419 doi: 10.1073/pnas.122623799
Varoqueaux, F., Sons, M. S., Plomp, J. J. & Brose, N. Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse. Mol. Cell. Biol. 25, 5973–5984 (2005).
pubmed: 15988013 pmcid: 1168806 doi: 10.1128/MCB.25.14.5973-5984.2005
Vaquero-Garcia, J. et al. A new view of transcriptome complexity and regulation through the lens of local splicing variations. eLife 5, e11752 (2016).
pubmed: 26829591 pmcid: 4801060 doi: 10.7554/eLife.11752
Thorvaldsdóttir, H., Robinson, J. T. & Mesirov, J. P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief. Bioinform. 14, 178–192 (2013).
pubmed: 22517427 doi: 10.1093/bib/bbs017
Rodriguez, J. M. et al. APPRIS 2017: principal isoforms for multiple gene sets. Nucleic Acids Res. 46, D213–D217 (2018).
pubmed: 29069475 doi: 10.1093/nar/gkx997
Middleton, R. et al. IRFinder: assessing the impact of intron retention on mammalian gene expression. Genome Biol. 18, 51 (2017).
pubmed: 28298237 pmcid: 5353968 doi: 10.1186/s13059-017-1184-4
Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647–661 (2014).
pubmed: 25307932 pmcid: 4253859 doi: 10.1016/j.cell.2014.09.029
Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, D766–D773 (2019).
pubmed: 30357393 doi: 10.1093/nar/gky955
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
pubmed: 24227677 doi: 10.1093/bioinformatics/btt656
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417–419 (2017).
pubmed: 28263959 pmcid: 5600148 doi: 10.1038/nmeth.4197
Mölder, F. et al. Sustainable data analysis with Snakemake. F1000Research 10, 33 (2021).
pubmed: 34035898 pmcid: 8114187 doi: 10.12688/f1000research.29032.2
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
pubmed: 20110278 pmcid: 2832824 doi: 10.1093/bioinformatics/btq033
Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2
pubmed: 11846609 doi: 10.1006/meth.2001.1262
Pereverzev, A. P. et al. Method for quantitative analysis of nonsense-mediated mRNA decay at the single cell level. Sci. Rep. 5, 7729 (2015).
pubmed: 25578556 pmcid: 4289894 doi: 10.1038/srep07729
Humphrey, J. et al. FUS ALS-causative mutations impair FUS autoregulation and splicing factor networks through intron retention. Nucleic Acids Res. 48, 6889–6905 (2020).
pubmed: 32479602 pmcid: 7337901 doi: 10.1093/nar/gkaa410
Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094–3100 (2018).
pubmed: 29750242 pmcid: 6137996 doi: 10.1093/bioinformatics/bty191
McGlincy, N. J. & Ingolia, N. T. Transcriptome-wide measurement of translation by ribosome profiling. Methods 126, 112–129 (2017).
pubmed: 28579404 pmcid: 5582988 doi: 10.1016/j.ymeth.2017.05.028
Lee, F. C. Y. et al. An improved iCLIP protocol. Preprint at https://doi.org/10.1101/2021.08.27.457890 (2021).
Wilkins, O. G., Capitanchik, C., Luscombe, N. M. & Ule, J. Ultraplex: A rapid, flexible, all-in-one fastq demultiplexer. Wellcome Open Res. 6, 141 (2021).
pubmed: 34286104 pmcid: 8287537 doi: 10.12688/wellcomeopenres.16791.1
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
pubmed: 22388286 pmcid: 3322381 doi: 10.1038/nmeth.1923
Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res. 27, 491–499 2017).
pubmed: 28100584 pmcid: 5340976 doi: 10.1101/gr.209601.116
Buniello, A. et al. The NHGRI-EBI GWAS catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019).
pubmed: 30445434 doi: 10.1093/nar/gky1120
Pruim, R. J. et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26, 2336–2337 (2010).
pubmed: 20634204 pmcid: 2935401 doi: 10.1093/bioinformatics/btq419
1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68–74 (2015).
doi: 10.1038/nature15393
Tam, O. H. et al. Postmortem cortex samples identify distinct molecular subtypes of ALS: retrotransposon activation, oxidative stress, and activated glia. Cell Rep. 29, 1164–1177.e5 (2019).
pubmed: 31665631 pmcid: 6866666 doi: 10.1016/j.celrep.2019.09.066
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
pubmed: 19505943 pmcid: 2723002 doi: 10.1093/bioinformatics/btp352
Picard toolkit. Broad Institute, GitHub Repository https://broadinstitute.github.io/picard/ (Broad Institute, 2019).
Cotto, K. C. et al. RegTools: Integrated analysis of genomic and transcriptomic data for the discovery of splicing variants in cancer. Preprint at https://doi.org/10.1101/436634 (2021)
Li, Y. I. et al. Annotation-free quantification of RNA splicing using LeafCutter. Nat. Genet. 50, 151–158 (2018).
pubmed: 29229983 doi: 10.1038/s41588-017-0004-9
Darmanis, S. et al. A survey of human brain transcriptome diversity at the single cell level. Proc. Natl Acad. Sci. USA 112, 7285–7290 (2015).
pubmed: 26060301 pmcid: 4466750 doi: 10.1073/pnas.1507125112
Hunt, G. J., Freytag, S., Bahlo, M. & Gagnon-Bartsch, J. A. dtangle: accurate and robust cell type deconvolution. Bioinformatics 35, 2093–2099 (2019).
pubmed: 30407492 doi: 10.1093/bioinformatics/bty926
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at https://arxiv.org/abs/1303.3997 (2013).
DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491–498 (2011).
pubmed: 21478889 pmcid: 3083463 doi: 10.1038/ng.806
McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297–1303 (2010).
pubmed: 20644199 pmcid: 2928508 doi: 10.1101/gr.107524.110
Lukavsky, P. J. et al. Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43. Nat. Struct. Mol. Biol. 20, 1443–1449 (2013).
pubmed: 24240615 doi: 10.1038/nsmb.2698

Auteurs

Anna-Leigh Brown (AL)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.

Oscar G Wilkins (OG)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
The Francis Crick Institute, London, UK.

Matthew J Keuss (MJ)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.

Sarah E Hill (SE)

National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.

Matteo Zanovello (M)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.

Weaverly Colleen Lee (WC)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.

Alexander Bampton (A)

Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London, UK.
Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.

Flora C Y Lee (FCY)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
The Francis Crick Institute, London, UK.

Laura Masino (L)

The Francis Crick Institute, London, UK.

Yue A Qi (YA)

Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.

Sam Bryce-Smith (S)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.

Ariana Gatt (A)

Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London, UK.
Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.

Martina Hallegger (M)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
The Francis Crick Institute, London, UK.

Delphine Fagegaltier (D)

Center for Genomics of Neurodegenerative Disease, New York Genome Center (NYGC), New York, NY, USA.

Hemali Phatnani (H)

Center for Genomics of Neurodegenerative Disease, New York Genome Center (NYGC), New York, NY, USA.

Jia Newcombe (J)

NeuroResource, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, London, UK.

Emil K Gustavsson (EK)

Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London, UK.
Great Ormond Street Institute of Child Health, Genetics and Genomic Medicine, University College London, London, UK.

Sahba Seddighi (S)

National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Joel F Reyes (JF)

National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.

Steven L Coon (SL)

Molecular Genomics Core, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Bethesda, MD, USA.

Daniel Ramos (D)

National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
Center for Alzheimer's and Related Dementias, National Institutes of Health, Bethesda, MD, USA.

Giampietro Schiavo (G)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
UK Dementia Research Institute, University College London, London, UK.

Elizabeth M C Fisher (EMC)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.

Towfique Raj (T)

Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ronald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Estelle and Daniel Maggin Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Maria Secrier (M)

Department of Genetics, Evolution and Environment, UCL Genetics Institute, University College London, London, UK.

Tammaryn Lashley (T)

Queen Square Brain Bank, UCL Queen Square Institute of Neurology, University College London, London, UK.
Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.

Jernej Ule (J)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK.
The Francis Crick Institute, London, UK.
Department of Molecular Biology and Nanobiotechnology, National Institute of Chemistry, Ljubljana, Slovenia.

Emanuele Buratti (E)

Molecular Pathology Lab, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.

Jack Humphrey (J)

Nash Family Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Ronald M. Loeb Center for Alzheimer's Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Estelle and Daniel Maggin Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Michael E Ward (ME)

National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA. wardme@nih.gov.

Pietro Fratta (P)

UCL Queen Square Motor Neuron Disease Centre, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, UCL, London, UK. p.fratta@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH